HLS Therapeutics (HLS) AGM 2026 summary

Opening remarks and agenda

• Meeting held virtually to ensure equal participation and voting access for all shareholders, with clear instructions for online engagement and voting.

• Four formal business matters addressed: financial statements, election of Directors, reappointment of Auditor, and approval of Long-Term Incentive Plan.

• Attendees introduced, including executive officers and nominees for Director positions.

Board and executive committee updates

• Eight nominees for Director positions were presented and confirmed, with no further nominations permitted per bylaws.

• Board and executive team roles and responsibilities reaffirmed, including contingency plans for meeting leadership.

Shareholder proposals

• No additional business or shareholder proposals were brought forward during the meeting.